HEMOBLAST Bellows
HEMOBLAST Bellows is a medical device with 9 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
55.6%
5 of 9 finished
44.4%
4 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery
Post-market Evaluation of HEMOBLAST™ Bellows in Spine Surgery
Post-Market Evaluation of HEMOBLAST™ Bellows in Open Gynecological, Urological, ENT, Head, Neck, and Vascular Surgeries
Post-Market Evaluation of HEMOBLAST™ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery
Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations
Clinical Trials (9)
Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery
Post-market Evaluation of HEMOBLAST™ Bellows in Spine Surgery
Post-Market Evaluation of HEMOBLAST™ Bellows in Open Gynecological, Urological, ENT, Head, Neck, and Vascular Surgeries
Post-Market Evaluation of HEMOBLAST™ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery
Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations
HEMOBLAST Pilot Clinical Investigation
HEMOBLAST Pivotal Clinical Investigation
Registry Study for the Use of HEMOBLAST™ Bellows in Abdominoplasty
Registry for the Use of HEMOBLAST Bellows in Total Knee Arthroplasty
All 9 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 9